oral glp 1 for weight loss FDA approves Foundayo, an GLP-1 alternative to Wegovy and Ozempic No injections 3 Takeaways from the Landmark

Compounded semaglutide is custom-prepared by compounding pharmacies and may vary in concentration or formulation

GLP-1 receptor agonists are licensed in the UK for type 2 diabetes and weight management, including semaglutide, dulaglutide, and liraglutide These medications reduce HbA1c by approximately 1.01.5 percentage points and improve both fasting and post-meal glucose levels Weight loss associated with GLP-1 therapy can lead to secondary improvements in insulin resistance, particularly through reduction of visceral fat Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhoea, which typically diminish over several weeks NICE recommends continuation only if patients achieve at least 1.0 percentage point HbA1c reduction within six months of treatment initiation Patients with diabetic retinopathy require close monitoring, and GLP-1 medications should be discontinued at least two months before planned pregnancy Table of Contents What Are GLP-1 Receptor Agonists and How Do They Work

H.KleerebezemM.et al

OBrien WT, Huang J, Buccafusca R, Garskof J, Valvezan AJ, Berry GT, et al

Some more than others experience structural barriers to food, nutrition and lifestyle skills

CGM-specific education should address device operation, data interpretation, insulin regimen optimization using Ambulatory Glucose Profile (AGP) data and glucose patterns, and trend arrows for insulin dosing adjustments